Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Schiff

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Opinion in Gastroenterology|October 13, 2006
Viral hepatitisRicardo Marrero, Eugene Schiff
Clinics in Liver Disease|October 9, 2013
Drug-induced cholestasisKalyan Ram Bhamidimarri, Eugene Schiff
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|January 8, 2017
Hepatotoxicity by herbs: a practical review of a neglected diseaseJean A Donet, Kay Sornmayura, Matthew Gulau, et al.
Digestive Diseases and Sciences|February 3, 2007
Hepatocellular carcinoma (HCC) with portal vein invasion, masquerading as pancreatic mass, diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)Ian Storch, Carmen Gomez, Francisco Contreras, et al.
Journal of Community Health|March 30, 2017
Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, FloridaErica B Feldman, Raymond Balise, Eugene Schiff, et al.
Journal of Clinical Gastroenterology|April 28, 2010
Metastatic squamous cell carcinoma to the liver presenting as hepatic cystsCarol J Morris, Gennaro Selvaggi, Andreas Tzakis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Cost-effectiveness of screening for chronic hepatitis C infection in the United StatesMark H Eckman, Andrew H Talal, Stuart C Gordon, et al.
Lancet (London, England)|January 17, 2009
In solidarity with GazaRami Abdou, Iyah Romm, Davida Schiff, et al.
Alimentary Pharmacology & Therapeutics|November 16, 2018
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver diseaseMitchell Shiffman, Bradley Freilich, Raj Vuppalanchi, et al.
Renal Failure|June 15, 2010
Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis populationVinaya Rao, Fabrizio Fabrizi, Phillip Pennell, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Opinion in Gastroenterology|October 13, 2006
Viral hepatitisRicardo Marrero, Eugene Schiff
Clinics in Liver Disease|October 9, 2013
Drug-induced cholestasisKalyan Ram Bhamidimarri, Eugene Schiff
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|January 8, 2017
Hepatotoxicity by herbs: a practical review of a neglected diseaseJean A Donet, Kay Sornmayura, Matthew Gulau, et al.
Digestive Diseases and Sciences|February 3, 2007
Hepatocellular carcinoma (HCC) with portal vein invasion, masquerading as pancreatic mass, diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)Ian Storch, Carmen Gomez, Francisco Contreras, et al.
Journal of Community Health|March 30, 2017
Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, FloridaErica B Feldman, Raymond Balise, Eugene Schiff, et al.
Journal of Clinical Gastroenterology|April 28, 2010
Metastatic squamous cell carcinoma to the liver presenting as hepatic cystsCarol J Morris, Gennaro Selvaggi, Andreas Tzakis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Cost-effectiveness of screening for chronic hepatitis C infection in the United StatesMark H Eckman, Andrew H Talal, Stuart C Gordon, et al.
Lancet (London, England)|January 17, 2009
In solidarity with GazaRami Abdou, Iyah Romm, Davida Schiff, et al.
Alimentary Pharmacology & Therapeutics|November 16, 2018
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver diseaseMitchell Shiffman, Bradley Freilich, Raj Vuppalanchi, et al.
Renal Failure|June 15, 2010
Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis populationVinaya Rao, Fabrizio Fabrizi, Phillip Pennell, et al.
Pageof 5